logo-loader

OptiBiotix Health CEO updates on new deal with Actial Farmaceutica and launch of WellBiome

Published: 16:07 01 Jul 2020 BST

OptiBiotix Health's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott following the news they've signed a distribution deal covering Australia, New Zealand, Indonesia, and Thailand for its cholesterol and blood pressure reducing dietary supplements, CholBiome and CholBiome X3. It's with Actial Farmaceutica - an Italian business with operations in Asia focused on probiotics and gut health. O'Hara also expands on the announcement from earlier this week around the launch of WellBiome, a blend of fibres and minerals to promote the diversity of the gut microbiome.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 28 minutes ago